je.st
news
Home
› Patheon Announces First Phase Of The UK Facility To Expand Early Development Capabilities In Europe
Patheon Announces First Phase Of The UK Facility To Expand Early Development Capabilities In Europe
2013-02-11 09:49:03| drugdiscoveryonline Home Page
With the first phase of additional investment to Patheon’s Milton Park facility, the company will be able to expand upon the early development capabilities currently being offered, including the introduction of the SoluPath program.
Tags: development
early
europe
expand
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||